Business PR Newswire FDA Lifts Clinical Hold on NUZ-001 rvrisingnetwork October 7, 2025 0 Highlights: U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®’s lead investigational therapy for ALS Clears the... Read More Read more about FDA Lifts Clinical Hold on NUZ-001
